Lack of association between inherited thrombophilic risk factors and idiopathic sudden sensorineural hearing loss in Italian patients

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 3, 2006, Pages 195-200

  Cadoni, Gabriella ^a   Scipione, Simona ^a   Rocca, Bianca ^a   Agostino, Stefania ^a   La Greca, Carmelo ^a   Bonvissuto, Davide ^a   Paludetti, Gaetano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Genetic polymorphism; Inheritance; Risk factor; Sudden sensorineural hearing loss; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; D DIMER; DEXTRAN; FIBRINOGEN; METHYLPREDNISOLONE; PLASMA SUBSTITUTE; PROTEIN C; PROTEIN S; PROTHROMBIN; STEROID;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONGENITAL DISORDER; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; ETHNIC GROUP; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; ITALY; MALE; PARTIAL THROMBOPLASTIN TIME; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOPHILIA;

EID: 33644913654     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500307     Document Type: Article

References (39)

1. Mattox DE. Medical management of sudden hearing loss. Otolaryngol Head Neck Surg 1980;88:111-3.
2. Wilkins SA Jr, Mattox DE, Lyles A. Evaluation of a "shot-gun" regimen for sudden hearing loss. Otolaryngol Head and Neck Surg 1987;97:474-80.
3. de Kleyn A. Sudden complete or partial loss of function of the octavus-system in an apparently normal person. Acta Otolaryngol (Stockh) 1944;32:407-25.
4. Hallberg OE. Sudden deafness of obscure origin. Laryngoscope 1956;66:1237-67.
5. Schuknecht HF, Kimura RS, Naufal PM. The pathology of sudden deafness. Acta Otolaryngol (Stockh) 1973;76:75-97.
6. Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope 1991;101:65-7.
7. Suckfull M, Wimmer C, Reichel O, Mees K, Schorn K. Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 2002;23:309-11.
8. Ruben RJ, Distenfeld A, Berg P, Carr R. Sudden sequential deafness as the presenting symptom of macroglobulinemia. JAMA 1969;209:1364-5.
9. Johnson A, Hawke M, Berger G. Sudden deafness and vertigo due to inner ear hemorrhage - a temporal bone case report. J Otolaryngol 1984;13:201-7.
10. Sando I, Egami T. Inner ear hemorrhage and endolymphatic hydrops in a leukemic patient with sudden hearing loss. Ann Otol Rhinol Laryngol 1977;86:518-24.
11. Gussen R. Sudden deafness as vascular origin: a human temporal bone study. Ann Otol Rhinol Laryngol 1976;85:94-100.
12. Belal A Jr. Pathology of vascular sensorineural hearing impairment. Laryngoscope 1980;90:1831-9.
13. Schuknecht HF, Donovan ED. The pathology of idiopathic sudden sensorineural hearing loss. Arch Otorhinolaryngol 1986;243:1-15.
14. Kronenberg J, Almagor M, Bendet E, Kushnir D. Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope 1992;102:65-8.
15. Probst R, Tschopp K, Ludin E, Kellerhals B, Podvinec M, Pfaltz CR. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol (Stockh) 1992;112:435-43.
16. Suzuki H, Furukawa M, Kumagai M, et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol (Stockh) 2003;123:46-50.
17. Ullrich D, Aurbach G, Drobik C. A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 1992;249:273-6.
18. Saito T, Sato K, Saito H. An experimental study of auditory dysfunction associated with hyperlipoproteinemia. Arch Otorhinolaryngol 1986;243:242-5.
19. Weissman JL, Curtin HD, Hirsch BE, Hirsch WL Jr. High signal from the otic labyrinth on unenhanced magnetic resonance imaging. AJNR Am J Neuroradiol 1992;13:1183-7.
20. Shinohara S, Yamamoto E, Saiwai S, et al. Clinical features of sudden hearing loss associated with a high signal in the labyrinth on unenhanced T1-weighted magnetic resonance imaging. Eur Arch Otorhinolaryngol 2000;257:480-4.
21. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-73.
22. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001;86:452-63.
23. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001;86:395-403.
24. Greaves M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry 1993;56:433-9.
25. Bertina RM. Genetic approach to thrombophilia. Thromb Haemost 2001;86:92-103.
26. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3.
27. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984;64:1297-300.
28. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993;90:1004-8.
29. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
30. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
31. Mercier E, Quere I, Chabert R, et al. The 20210A allele of the prothrombin gene is an independent risk factor for perception deafness in patients with venous thromboembolic antecedents [Letter]. Blood 1999;93:3150-2.
32. Patscheke JH, Arndt J, Dietz K, Zenner HP, Reuner KH. The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients. Thromb Haemost 2001;86:1118-9.
33. Rudack C, Langer C, Junker R. Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss. Hear Res 2004;191:41-8.
34. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975;8:467-73.
35. Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost 1999;82:1395-8.
36. Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-30.
37. Zuber M, Toulon P, Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 1996;27:1721-3.
38. Cadoni G, Agostino S, Scipione S, Galli J. Low serum folate levels: a risk factor for sudden sensorineural hearing loss? Acta Otolaryngol (Stockh) 2004;124:608-11.
39. Corral J, Zuazu-Jausoro I, Rivera J, González-Conejero R, Ferrer F, Vicente V. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family. Br J Haematol 1999;105:560-3.